US Public Health Pathogens Genomics Centers of Excellence
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement program to establish The US Pathogen Genomics Centers of Excellence (PGCoE) network.
The underlying objective of the PGCoE network is, through partnerships between academic and public-health organizations, to foster innovation in pathogen genomics and molecular epidemiology in order to improve the control of and response to microbial threats of public-health importance.
This NOFO will implement a three-pronged strategy of 1) accelerated translation of relevant pathogen genomic technologies and innovations into the US public health system, particularly in public health agencies at the local, state, tribal, territorial and national level; 2) training of the public health workforce in microbial genomics and genomic epidemiology; and 3) rapid and scalable use of pathogen genomics in responding to public health emergencies from infectious diseases in order to improve detection, characterization, and prevention of infectious disease threats.
The underlying objective of the PGCoE network is, through partnerships between academic and public-health organizations, to foster innovation in pathogen genomics and molecular epidemiology in order to improve the control of and response to microbial threats of public-health importance.
This NOFO will implement a three-pronged strategy of 1) accelerated translation of relevant pathogen genomic technologies and innovations into the US public health system, particularly in public health agencies at the local, state, tribal, territorial and national level; 2) training of the public health workforce in microbial genomics and genomic epidemiology; and 3) rapid and scalable use of pathogen genomics in responding to public health emergencies from infectious diseases in order to improve detection, characterization, and prevention of infectious disease threats.
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control - NCEZID
Estimated Funding: $185,000,000
Office: Centers for Disease Control - NCEZID
Estimated Funding: $185,000,000
Obtain Full Opportunity Text:
Full solicitation
Additional Information of Eligibility:
To be deemed responsive, applications must include an Academic Letter of Support from at least one academic partner organization.
If an applicant fails to submit at least one letter of support from an academic partner organization, the application will be deemed non-responsive and will receive no further review. Applicants must clearly state in the Project Abstract Summary if they are applying to only the Mandatory Components (Core, Response Implementation), or if they are applying to both the Mandatory Components (Core, Response Implementation) and Optional Component (Lead PGCoE for Education).
When including this information in the Project Abstract Summary, please indicate one of the following: a) “This application is only for the Mandatory Components (Core, Response Implementation)” or b) “This application is for the Mandatory Components (Core, Response Implementation) and also includes the Optional Component (Lead PGCoE for Education).” If an applicant fails to clearly state which components are being applied for in the Project Abstract, the application will be deemed non-responsive and will receive no further review.
State, local, Tribal, or territorial public health departments or public health laboratories per ARP Sec.
2402: "FUNDING FOR SARS–COV–2 GENOMIC SEQUENCING AND SURVEILLANCE.
(a) In General.—In addition to amounts otherwise available, there is appropriated to the Secretary for fiscal year 2021 out of any money in the Treasury not otherwise appropriated, $1,750,000,000, to remain available until expended, to strengthen and expand activities and workforce related to genomic sequencing, analytics, and disease surveillance.
(b) Use Of Funds.—From amounts appropriated by subsection (a), the Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall— (1) conduct, expand, and improve activities to sequence genomes, identify mutations, and survey the circulation and transmission of viruses and other organisms, including strains of SARS–CoV–2; (2) award grants or cooperative agreements to State, local, Tribal, or territorial public health departments or public health laboratories— (A) to increase their capacity to sequence genomes of circulating strains of viruses and other organisms, including SARS–CoV–2; (B) to identify mutations in viruses and other organisms, including SARS–CoV–2; (C) to use genomic sequencing to identify outbreaks and clusters of diseases or infections, including COVID–19; and (D) to develop effective disease response strategies based on genomic sequencing and surveillance data; (3) enhance and expand the informatics capabilities of the public health workforce; and (4) award grants for the construction, alteration, or renovation of facilities to improve genomic sequencing and surveillance capabilities at the State and local level."
Full Opportunity Web Address:
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={7A16C460-2B31-C624-23EA-94C99F132E0E}
Contact:
Agency Email Description:
pgcoecoag@cdc.gov
Agency Email:
Date Posted:
2022-03-18
Application Due Date:
Archive Date:
2022-06-17
Social Entrepreneurship
Spotlight
Keeping Half the Profits Beats Non-profits for Social Impact
Melbourne social enterprise Who Gives A Crap sold nearly 3 million rolls of toilet paper in 2014/15 and gave half the proceeds to WaterAid Australia, but co-founder Simon Griffiths says the donation would have been less had the startup adopted a non-profit model when it launched two years ago.
Learn How to Identify and Avoid Grant Scams
